Indaptus Therapeutics, Inc. (INDP) Stock on an Increasing Trajectory, Here’s Why

Indaptus Therapeutics, Inc. (INDP), a pre-clinical stage biotech company, has surged 17.02% in aftermarket trading session. Consequently, INDP stock is trading at $7.22 at the time of the writing. On Monday, INDP closed the day at $6.17 after soaring 8.25% in regular trading hours. The consistent increase could be attributed to the appointment of a […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.